logo
Login

INDOCO REMEDIES LTD. (INDOCO) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Indoco Remedies (Indoco) is a Mumbai-based pharmaceutical company that focuses on formulations with a presence in contract manufacturing and research. The Company is engaged in the manufacturing and marketing of pharmaceutical Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredien…

INDOCOUpdated 1 Sept 2026, 17:18

Indoco Remedies Ltd.

Market Cap

₹2,250Cr.

Current Price

₹244

High / Low

₹332/162

Stock P/E

105

ROE-0.28%
ROCE4.33%
Book Value₹119
Face Value₹2.00
Dividend Yield0.08%

About

Indoco Remedies (Indoco) is a Mumbai-based pharmaceutical company that focuses on formulations with a presence in contract manufacturing and research. The Company is engaged in the manufacturing and marketing of pharmaceutical Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days6668737373696970778390117
Inventory Days179173188204209230245248228207299235
Days Payable1451371671581951841191088979121190
Cash Conversion Cycle1001039511988115195210217211267162
Working Capital Days464840382121597781645647
ROCE %21%17%12%7%1%6%16%23%17%12%3%4%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 1 September 2026 at 17:18

Designed & Shipped by Harshit Bansal